Veracyte Inc (VCYT, Financial) is set to release its Q3 2024 earnings on Nov 6, 2024. The consensus estimate for Q3 2024 revenue is $109.87 million, and the earnings are expected to come in at $0.05 per share. The full year 2024's revenue is expected to be $436.11 million and the earnings are expected to be $0.18 per share. More detailed estimate data can be found on the Forecast page.
Veracyte Inc (VCYT, Financial) Estimates Trends
Over the past 90 days, revenue estimates for Veracyte Inc (VCYT) for the full year 2024 have increased from $406.27 million to $436.11 million and for 2025 from $449.21 million to $480.86 million. Similarly, earnings estimates for the full year 2024 have risen from -$0.01 per share to $0.18 per share, and for 2025 from $0.14 per share to $0.41 per share.
Veracyte Inc (VCYT, Financial) Reported History
In the previous quarter of 2024-06-30, Veracyte Inc's (VCYT) actual revenue was $114.43 million, which beat analysts' revenue expectations of $100.275 million by 14.11%. Veracyte Inc's (VCYT) actual earnings were $0.07 per share, which beat analysts' earnings expectations of -$0.01 per share by 800%. After releasing the results, Veracyte Inc (VCYT) was up by 23.97% in one day.
Veracyte Inc (VCYT, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 9 analysts, the average target price for Veracyte Inc (VCYT) is $38 with a high estimate of $43 and a low estimate of $26. The average target implies an upside of 8.51% from the current price of $35.02.
Based on GuruFocus estimates, the estimated GF Value for Veracyte Inc (VCYT, Financial) in one year is $35.47, suggesting an upside of 1.28% from the current price of $35.02.
Based on the consensus recommendation from 11 brokerage firms, Veracyte Inc's (VCYT, Financial) average brokerage recommendation is currently 1.9, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
